Literature DB >> 7637009

Monoclonal antibodies against Rous sarcoma virus integrase protein exert differential effects on integrase function in vitro.

B Müller1, D Bizub-Bender, M D Andrake, K S Jones, A M Skalka.   

Abstract

We have prepared and characterized several monoclonal antibodies (MAbs) against the Rous sarcoma virus integrase protein (IN) with the aim of employing these specific reagents as tools for biochemical and biophysical studies. The interaction of IN with the purified MAbs and their Fab fragment derivatives was demonstrated by Western blot (immunoblot), enzyme-linked immunosorbent assay, and size exclusion chromatography. A series of truncated IN proteins was used to determine regions in the protein important for recognition by the antibodies. The MAbs described here recognize epitopes that lie within the catalytic core region of IN (amino acids 50 to 207) and are likely to be conformational. A detailed functional analysis was carried out by investigating the effects of Fab fragments as well as of intact MAbs on the activities of IN in vitro. These studies revealed differential effects which fall into three categories. (i) One of the antibodies completely neutralized the processing as well as the joining activity and also reduced the DNA binding capacity as determined by a nitrocellulose filter binding assay. On the other hand, this MAb did not abolish the cleavage-ligation reaction on a disintegration substrate and the nonspecific cleavage of DNA by IN. The cleavage pattern generated by the IN-MAb complex on various DNA substrates closely resembled that produced by mutant IN proteins which show a deficiency in multimerization. Preincubation of IN with substrate protected the enzyme from inhibition by this antibody. (ii) Two other antibodies showed a general inhibition of all IN activities tested. (iii) In contrast, a fourth MAb stimulated the in vitro joining activity of IN. Size exclusion chromatography demonstrated that IN-Fab complexes from representatives of the three categories of MAbs exhibit different stoichiometric compositions that suggest possible explanations for their contrasting effects and may provide clues to the relationship between the structure and function of IN.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7637009      PMCID: PMC189419     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Residues critical for retroviral integrative recombination in a region that is highly conserved among retroviral/retrotransposon integrases and bacterial insertion sequence transposases.

Authors:  J Kulkosky; K S Jones; R A Katz; J P Mack; A M Skalka
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

2.  Reversal of integration and DNA splicing mediated by integrase of human immunodeficiency virus.

Authors:  S A Chow; K A Vincent; V Ellison; P O Brown
Journal:  Science       Date:  1992-02-07       Impact factor: 47.728

3.  Defining nucleic acid-binding properties of avian retrovirus integrase by deletion analysis.

Authors:  S R Mumm; D P Grandgenett
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

4.  Retroviral integrase domains: DNA binding and the recognition of LTR sequences.

Authors:  E Khan; J P Mack; R A Katz; J Kulkosky; A M Skalka
Journal:  Nucleic Acids Res       Date:  1991-02-25       Impact factor: 16.971

5.  The avian retroviral IN protein is both necessary and sufficient for integrative recombination in vitro.

Authors:  R A Katz; G Merkel; J Kulkosky; J Leis; A M Skalka
Journal:  Cell       Date:  1990-10-05       Impact factor: 41.582

6.  Human immunodeficiency virus integration protein expressed in Escherichia coli possesses selective DNA cleaving activity.

Authors:  P A Sherman; J A Fyfe
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

7.  Human immunodeficiency virus type 1 integration protein: DNA sequence requirements for cleaving and joining reactions.

Authors:  P A Sherman; M L Dickson; J A Fyfe
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

8.  DNA binding properties of the integrase proteins of human immunodeficiency viruses types 1 and 2.

Authors:  D C van Gent; Y Elgersma; M W Bolk; C Vink; R H Plasterk
Journal:  Nucleic Acids Res       Date:  1991-07-25       Impact factor: 16.971

9.  Activities and substrate specificity of the evolutionarily conserved central domain of retroviral integrase.

Authors:  J Kulkosky; R A Katz; G Merkel; A M Skalka
Journal:  Virology       Date:  1995-01-10       Impact factor: 3.616

10.  DNA-induced dimerization of the Escherichia coli rep helicase. Allosteric effects of single-stranded and duplex DNA.

Authors:  I Wong; K L Chao; W Bujalowski; T M Lohman
Journal:  J Biol Chem       Date:  1992-04-15       Impact factor: 5.157

View more
  3 in total

1.  The cellular protein daxx interacts with avian sarcoma virus integrase and viral DNA to repress viral transcription.

Authors:  James G Greger; Richard A Katz; Alexander M Ishov; Gerd G Maul; Anna Marie Skalka
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

2.  Subcellular localization and integration activities of rous sarcoma virus reverse transcriptase.

Authors:  Susanne Werner; Patrick Hindmarsh; Markus Napirei; Karin Vogel-Bachmayr; Birgitta M Wöhrl
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

3.  Nonspecific alcoholysis, a novel endonuclease activity of human immunodeficiency virus type 1 and other retroviral integrases.

Authors:  M Katzman; M Sudol
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.